Skip to main content
Default Image

Perspectives: Pelosi’s Aggressive Drug Pricing Plan Doesn’t Even Have To Pass To Scare Pharma

Stat: Insulin Shows Why We Need A Public Option In The Pharma Industry: When Frederick Banting, Charles Best, and James Collip filed for a U.S. patent on insulin in 1923 and sold it to the University of Toronto for $1 each, they did it because, as Best once said, “insulin belongs to the world. ”They also believed that securing the patent was a form of publication, and wrote to the university president, “When the details of the method of preparation are published anyone would be free to prepare the extract, but no one could secure a profitable monopoly. ”Sadly, they were mistaken.” (Dana Brown and Elizabeth Pfiester, 9/10)

Publication date: 2019-09-10
Parent publication: Kaiser Health News
Publication URL: https://khn.org/morning-breakout/perspectives-pelosis-aggressive-drug-pricing-plan-doesnt-even-have-to-pass-to-scare-pharma/

More related work

Medicine Cost

Americans deserve publicly owned generic drugs

Bold policies could have saved America’s largest generic drug plant, but it’s never too late to start putting communities first.

read more
Illustration courtesy of United Nations

All health is public health: Busting the myths of choice and commodity

For decades, we have been sold a myth of private health. It is a myth that our health is largely a product of individual choices and personal responsibilities. It is a myth that our healthcare is a service that private corporations can provide, and for which we must pay to survive. But the COVID-19

read more
Neil McInroy (Source: Coop News)

Neil McInroy joins TDC to advise stepped-up community wealth building program

The former CEO of a leading UK economic think tank will be central in helping build capacity to offer powerful new technical assistance to cities and local authorities pursuing community wealth building strategies.

read more